IndieBio is a leading biotech accelerator founded in 2014, operating under SOSV, a global venture capital firm. With locations in San Francisco and New York, IndieBio provides multi-stage investment and unique access to wet lab infrastructure, enabling startups to conduct biological experiments and develop prototypes. The program emphasizes diversity and supports companies tackling significant health and environmental challenges.

IndieBio invests in sectors where biology can create innovative solutions, including climate tech, food, therapeutics, and materials. The program is designed for pre-seed stage companies and continues to support them through follow-on investments, fostering a diverse portfolio with a notable percentage of female founders.

IndieBio offers a comprehensive support system for biotech startups, including initial investments of up to $525K, access to BSL-2 wet labs, scientific mentorship, business development support, and a global network of over 1,000 portfolio companies through SOSV.

Q: What is the duration of the program? A: The program lasts approximately 4 months. Q: How many cohorts are there each year? A: IndieBio runs 2 cohorts per year. Q: What is the investment amount? A: The initial investment is $250K for 6-8% equity, with potential follow-on funding.